

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | serine family amino acid catabolic process (GO:0009071) | 4.86140951 |
| 2 | protein targeting to Golgi (GO:0000042) | 4.43092208 |
| 3 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 4.35176656 |
| 4 | establishment of protein localization to Golgi (GO:0072600) | 4.33622605 |
| 5 | CDP-diacylglycerol metabolic process (GO:0046341) | 4.18379906 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.14584633 |
| 7 | glycine metabolic process (GO:0006544) | 4.01255674 |
| 8 | vitamin transmembrane transport (GO:0035461) | 3.94794356 |
| 9 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.93941028 |
| 10 | NADH metabolic process (GO:0006734) | 3.91611690 |
| 11 | cysteine metabolic process (GO:0006534) | 3.89156918 |
| 12 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.75477197 |
| 13 | negative regulation of inclusion body assembly (GO:0090084) | 3.66806687 |
| 14 | L-phenylalanine catabolic process (GO:0006559) | 3.66170206 |
| 15 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.66170206 |
| 16 | pantothenate metabolic process (GO:0015939) | 3.61567267 |
| 17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.56396330 |
| 18 | L-phenylalanine metabolic process (GO:0006558) | 3.56396330 |
| 19 | serine family amino acid metabolic process (GO:0009069) | 3.53731054 |
| 20 | amino-acid betaine metabolic process (GO:0006577) | 3.50718408 |
| 21 | biotin metabolic process (GO:0006768) | 3.45088382 |
| 22 | fatty acid transmembrane transport (GO:1902001) | 3.41130180 |
| 23 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.36757242 |
| 24 | carnitine shuttle (GO:0006853) | 3.35591488 |
| 25 | alpha-linolenic acid metabolic process (GO:0036109) | 3.35274091 |
| 26 | neurotransmitter catabolic process (GO:0042135) | 3.34044525 |
| 27 | histone H3-K9 demethylation (GO:0033169) | 3.32287556 |
| 28 | positive regulation of receptor recycling (GO:0001921) | 3.27387800 |
| 29 | fructose metabolic process (GO:0006000) | 3.23967388 |
| 30 | response to pheromone (GO:0019236) | 3.23238773 |
| 31 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.22818620 |
| 32 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.20034315 |
| 33 | folic acid metabolic process (GO:0046655) | 3.17889527 |
| 34 | purine nucleobase biosynthetic process (GO:0009113) | 3.11506117 |
| 35 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.10417282 |
| 36 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.07956362 |
| 37 | urea cycle (GO:0000050) | 3.07950507 |
| 38 | urea metabolic process (GO:0019627) | 3.07950507 |
| 39 | cellular response to ethanol (GO:0071361) | 3.07205385 |
| 40 | 2-oxoglutarate metabolic process (GO:0006103) | 3.06838425 |
| 41 | fatty acid homeostasis (GO:0055089) | 3.06248351 |
| 42 | lysine metabolic process (GO:0006553) | 3.05351119 |
| 43 | lysine catabolic process (GO:0006554) | 3.05351119 |
| 44 | aromatic amino acid family catabolic process (GO:0009074) | 3.05181515 |
| 45 | negative regulation of macroautophagy (GO:0016242) | 3.04821941 |
| 46 | sulfur amino acid catabolic process (GO:0000098) | 3.03896968 |
| 47 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.01873230 |
| 48 | macroautophagy (GO:0016236) | 3.01856725 |
| 49 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.99187509 |
| 50 | negative regulation of cell killing (GO:0031342) | 2.99187509 |
| 51 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.98451648 |
| 52 | Golgi to endosome transport (GO:0006895) | 2.98092621 |
| 53 | homocysteine metabolic process (GO:0050667) | 2.95020498 |
| 54 | folic acid transport (GO:0015884) | 2.93721198 |
| 55 | alpha-amino acid catabolic process (GO:1901606) | 2.93252950 |
| 56 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.92835131 |
| 57 | kynurenine metabolic process (GO:0070189) | 2.92619252 |
| 58 | cellular ketone body metabolic process (GO:0046950) | 2.91760517 |
| 59 | bile acid biosynthetic process (GO:0006699) | 2.90253601 |
| 60 | glutamate metabolic process (GO:0006536) | 2.88401680 |
| 61 | histone H3-K36 demethylation (GO:0070544) | 2.88255771 |
| 62 | serine family amino acid biosynthetic process (GO:0009070) | 2.87497069 |
| 63 | acrosome reaction (GO:0007340) | 2.86534721 |
| 64 | cellular response to epinephrine stimulus (GO:0071872) | 2.86499483 |
| 65 | negative regulation of neurotransmitter transport (GO:0051589) | 2.86430037 |
| 66 | microglial cell activation (GO:0001774) | 2.85773467 |
| 67 | acetyl-CoA metabolic process (GO:0006084) | 2.82675405 |
| 68 | nitrogen cycle metabolic process (GO:0071941) | 2.81761558 |
| 69 | cellular amino acid catabolic process (GO:0009063) | 2.80947766 |
| 70 | relaxation of cardiac muscle (GO:0055119) | 2.78687574 |
| 71 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.77197097 |
| 72 | mitotic metaphase plate congression (GO:0007080) | 2.76427338 |
| 73 | autophagic vacuole assembly (GO:0000045) | 2.76411165 |
| 74 | regulation of triglyceride catabolic process (GO:0010896) | 2.76130879 |
| 75 | regulation of synaptic vesicle transport (GO:1902803) | 2.75895420 |
| 76 | aspartate family amino acid catabolic process (GO:0009068) | 2.74195155 |
| 77 | regulation of bile acid biosynthetic process (GO:0070857) | 2.73007377 |
| 78 | triglyceride homeostasis (GO:0070328) | 2.72580681 |
| 79 | acylglycerol homeostasis (GO:0055090) | 2.72580681 |
| 80 | bile acid metabolic process (GO:0008206) | 2.72457628 |
| 81 | aromatic amino acid family metabolic process (GO:0009072) | 2.72018326 |
| 82 | protein localization to Golgi apparatus (GO:0034067) | 2.70949627 |
| 83 | negative regulation of fibrinolysis (GO:0051918) | 2.70699947 |
| 84 | lung-associated mesenchyme development (GO:0060484) | 2.70129649 |
| 85 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.69706444 |
| 86 | regulation of cholesterol homeostasis (GO:2000188) | 2.68382903 |
| 87 | alditol metabolic process (GO:0019400) | 2.67024397 |
| 88 | protein K11-linked deubiquitination (GO:0035871) | 2.66902460 |
| 89 | nerve growth factor signaling pathway (GO:0038180) | 2.65534473 |
| 90 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.64653797 |
| 91 | triglyceride biosynthetic process (GO:0019432) | 2.64268567 |
| 92 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.64176330 |
| 93 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.64046998 |
| 94 | neutral lipid catabolic process (GO:0046461) | 2.63286061 |
| 95 | acylglycerol catabolic process (GO:0046464) | 2.63286061 |
| 96 | vesicle transport along microtubule (GO:0047496) | 2.63158095 |
| 97 | regulation of sequestering of triglyceride (GO:0010889) | 2.62752050 |
| 98 | carnitine transmembrane transport (GO:1902603) | 2.62275852 |
| 99 | positive regulation of Rap GTPase activity (GO:0032854) | 2.62188474 |
| 100 | regulation of ARF protein signal transduction (GO:0032012) | 2.61539340 |
| 101 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.60621272 |
| 102 | heme transport (GO:0015886) | 2.60196689 |
| 103 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.59953295 |
| 104 | S-adenosylmethionine metabolic process (GO:0046500) | 2.59509466 |
| 105 | regulation of protein activation cascade (GO:2000257) | 2.59192234 |
| 106 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.58102032 |
| 107 | neuromuscular process controlling posture (GO:0050884) | 2.57824580 |
| 108 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.57373134 |
| 109 | positive regulation of lipid catabolic process (GO:0050996) | 2.57221960 |
| 110 | labyrinthine layer development (GO:0060711) | 2.56414538 |
| 111 | carnitine transport (GO:0015879) | 2.56279756 |
| 112 | amino-acid betaine transport (GO:0015838) | 2.56279756 |
| 113 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.55898187 |
| 114 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.55784600 |
| 115 | dicarboxylic acid catabolic process (GO:0043649) | 2.55659254 |
| 116 | regulation of translational termination (GO:0006449) | 2.55344627 |
| 117 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.54731362 |
| 118 | interkinetic nuclear migration (GO:0022027) | 2.54490907 |
| 119 | acylglycerol biosynthetic process (GO:0046463) | 2.54073119 |
| 120 | neutral lipid biosynthetic process (GO:0046460) | 2.54073119 |
| 121 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.53896266 |
| 122 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.53473492 |
| 123 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.52867867 |
| 124 | triglyceride catabolic process (GO:0019433) | 2.52026370 |
| 125 | regulation of relaxation of muscle (GO:1901077) | 2.50002399 |
| 126 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.49957870 |
| 127 | skeletal muscle adaptation (GO:0043501) | 2.48787454 |
| 128 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.48107510 |
| 129 | hepatocyte apoptotic process (GO:0097284) | 2.47807445 |
| 130 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.47645535 |
| 131 | ketone body metabolic process (GO:1902224) | 2.47152669 |
| 132 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.46582186 |
| 133 | indole-containing compound catabolic process (GO:0042436) | 2.46142608 |
| 134 | indolalkylamine catabolic process (GO:0046218) | 2.46142608 |
| 135 | tryptophan catabolic process (GO:0006569) | 2.46142608 |
| 136 | intestinal epithelial cell development (GO:0060576) | 2.46012563 |
| 137 | response to epinephrine (GO:0071871) | 2.45565927 |
| 138 | organic acid catabolic process (GO:0016054) | 2.45519278 |
| 139 | carboxylic acid catabolic process (GO:0046395) | 2.45519278 |
| 140 | glyoxylate metabolic process (GO:0046487) | 2.45329778 |
| 141 | glutamine family amino acid catabolic process (GO:0009065) | 2.45296297 |
| 142 | high-density lipoprotein particle remodeling (GO:0034375) | 2.44868453 |
| 143 | regulation of complement activation (GO:0030449) | 2.44643464 |
| 144 | regulation of protein glycosylation (GO:0060049) | 2.44634217 |
| 145 | complement activation, alternative pathway (GO:0006957) | 2.44129102 |
| 146 | peptidyl-threonine phosphorylation (GO:0018107) | 2.44011979 |
| 147 | synaptic vesicle maturation (GO:0016188) | 2.43727543 |
| 148 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.43644318 |
| 149 | regulation of Rap GTPase activity (GO:0032317) | 2.41895419 |
| 150 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.41592476 |
| 151 | early endosome to late endosome transport (GO:0045022) | 2.39890766 |
| 152 | histone lysine demethylation (GO:0070076) | 2.39842280 |
| 153 | locomotory exploration behavior (GO:0035641) | 2.39283507 |
| 154 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.39142069 |
| 155 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.39001510 |
| 156 | detection of molecule of bacterial origin (GO:0032490) | 2.36583945 |
| 157 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.35639160 |
| 158 | B cell receptor signaling pathway (GO:0050853) | 2.34955215 |
| 159 | regulation of gamma-delta T cell activation (GO:0046643) | 2.34256499 |
| 160 | regulation of beta-amyloid formation (GO:1902003) | 2.33709974 |
| 161 | potassium ion import (GO:0010107) | 2.32511082 |
| 162 | macrophage activation (GO:0042116) | 2.32398157 |
| 163 | macrophage activation involved in immune response (GO:0002281) | 2.31670325 |
| 164 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.31435917 |
| 165 | regulation of receptor recycling (GO:0001919) | 2.30009920 |
| 166 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.29881463 |
| 167 | histone demethylation (GO:0016577) | 2.29194232 |
| 168 | myofibril assembly (GO:0030239) | 2.28538984 |
| 169 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.27517664 |
| 170 | cellular response to monoamine stimulus (GO:0071868) | 2.27486033 |
| 171 | cellular response to catecholamine stimulus (GO:0071870) | 2.27486033 |
| 172 | regulation of Rac protein signal transduction (GO:0035020) | 2.26120674 |
| 173 | striated muscle atrophy (GO:0014891) | 2.23810273 |
| 174 | positive regulation of fibroblast migration (GO:0010763) | 2.23063502 |
| 175 | cardiac muscle hypertrophy (GO:0003300) | 2.22006707 |
| 176 | calcium ion-dependent exocytosis (GO:0017156) | 2.21578883 |
| 177 | nucleus localization (GO:0051647) | 2.20027267 |
| 178 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.19957976 |
| 179 | peptidyl-threonine modification (GO:0018210) | 2.19430964 |
| 180 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.19200678 |
| 181 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.19160782 |
| 182 | positive regulation of granulocyte differentiation (GO:0030854) | 2.19081407 |
| 183 | negative regulation of protein oligomerization (GO:0032460) | 2.18158851 |
| 184 | cerebellar granule cell differentiation (GO:0021707) | 2.17945540 |
| 185 | regulation of platelet aggregation (GO:0090330) | 2.17153395 |
| 186 | phospholipid dephosphorylation (GO:0046839) | 2.16992939 |
| 187 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.16801541 |
| 188 | relaxation of muscle (GO:0090075) | 2.15576736 |
| 189 | sodium ion export (GO:0071436) | 2.15437649 |
| 190 | regulation of Rab GTPase activity (GO:0032313) | 2.13858246 |
| 191 | positive regulation of Rab GTPase activity (GO:0032851) | 2.13858246 |
| 192 | positive regulation of glycolytic process (GO:0045821) | 2.13031641 |
| 193 | response to catecholamine (GO:0071869) | 2.10429478 |
| 194 | response to monoamine (GO:0071867) | 2.10429478 |
| 195 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.09061595 |
| 196 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.09058199 |
| 197 | striated muscle hypertrophy (GO:0014897) | 2.08559057 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 5.58643853 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.34969310 |
| 3 | ZNF263_19887448_ChIP-Seq_K562_Human | 4.65165096 |
| 4 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.88776817 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.67501522 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.32585383 |
| 7 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.17931124 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.05025467 |
| 9 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.73968147 |
| 10 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.63899707 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.63158194 |
| 12 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.48149502 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.45658488 |
| 14 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.35800716 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.31456241 |
| 16 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.23381420 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.19615134 |
| 18 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.14485170 |
| 19 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.10722670 |
| 20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.00918482 |
| 21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.89965239 |
| 22 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.82202476 |
| 23 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.81930228 |
| 24 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.78874008 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.72626464 |
| 26 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.70216005 |
| 27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.68227438 |
| 28 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.66022485 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.61225459 |
| 30 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.61145280 |
| 31 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.60320958 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.59262917 |
| 33 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.58094172 |
| 34 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.56896357 |
| 35 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.56605695 |
| 36 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.52798465 |
| 37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.51413991 |
| 38 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.49021843 |
| 39 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.48495732 |
| 40 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.47062053 |
| 41 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.46704415 |
| 42 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.45974506 |
| 43 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.45534726 |
| 44 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.43933148 |
| 45 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.42066786 |
| 46 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.41624899 |
| 47 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41189499 |
| 48 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.41189499 |
| 49 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.41015531 |
| 50 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39754199 |
| 51 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.37842214 |
| 52 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.37723447 |
| 53 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.37496080 |
| 54 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.36875055 |
| 55 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.35979422 |
| 56 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.35109415 |
| 57 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.33100885 |
| 58 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.31986737 |
| 59 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.31392062 |
| 60 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.30113326 |
| 61 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.28977408 |
| 62 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.28108794 |
| 63 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27520645 |
| 64 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27440825 |
| 65 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.27391200 |
| 66 | P300_19829295_ChIP-Seq_ESCs_Human | 1.26840461 |
| 67 | TCF4_23295773_ChIP-Seq_U87_Human | 1.25966316 |
| 68 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.25606458 |
| 69 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24934205 |
| 70 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.24839880 |
| 71 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.24793955 |
| 72 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.24547889 |
| 73 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.24430676 |
| 74 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.24076270 |
| 75 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23676359 |
| 76 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.22729867 |
| 77 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.22689658 |
| 78 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.21381662 |
| 79 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.21317812 |
| 80 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.20747281 |
| 81 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20567703 |
| 82 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.19454161 |
| 83 | FUS_26573619_Chip-Seq_HEK293_Human | 1.18260922 |
| 84 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.17696045 |
| 85 | GATA2_19941826_ChIP-Seq_K562_Human | 1.17617089 |
| 86 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.17219481 |
| 87 | AR_25329375_ChIP-Seq_VCAP_Human | 1.17085535 |
| 88 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.16971937 |
| 89 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.16812424 |
| 90 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.16664298 |
| 91 | TP53_16413492_ChIP-PET_HCT116_Human | 1.16341902 |
| 92 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.15955602 |
| 93 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.15948080 |
| 94 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.15884562 |
| 95 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.15051780 |
| 96 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14936149 |
| 97 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.14415840 |
| 98 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.14064221 |
| 99 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.13817071 |
| 100 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.12765940 |
| 101 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.12732834 |
| 102 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.12732834 |
| 103 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.12643303 |
| 104 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.12421115 |
| 105 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.12133235 |
| 106 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10995684 |
| 107 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.09883295 |
| 108 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09771271 |
| 109 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.09083594 |
| 110 | KLF4_19829295_ChIP-Seq_ESCs_Human | 1.08089780 |
| 111 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.07649902 |
| 112 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.07113837 |
| 113 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.06778379 |
| 114 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05864377 |
| 115 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.04706378 |
| 116 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04705941 |
| 117 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.04319544 |
| 118 | KDM2B_26808549_Chip-Seq_REH_Human | 1.03800462 |
| 119 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.03629930 |
| 120 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.03289171 |
| 121 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.02334402 |
| 122 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.01080563 |
| 123 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.00789859 |
| 124 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.00690318 |
| 125 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.00426167 |
| 126 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00184779 |
| 127 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.00175112 |
| 128 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.99397926 |
| 129 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.99253041 |
| 130 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.99034203 |
| 131 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.98242028 |
| 132 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.98235147 |
| 133 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.97711830 |
| 134 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.97546453 |
| 135 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97487928 |
| 136 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97436159 |
| 137 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97381778 |
| 138 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97298965 |
| 139 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.95969795 |
| 140 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.95591703 |
| 141 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.94897812 |
| 142 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.93439802 |
| 143 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.93165257 |
| 144 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.92714567 |
| 145 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.92354055 |
| 146 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.91880061 |
| 147 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.88798401 |
| 148 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.87694516 |
| 149 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.87528340 |
| 150 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.87464661 |
| 151 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.85476350 |
| 152 | * NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.83144918 |
| 153 | * PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.81401936 |
| 154 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.81017987 |
| 155 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.80964725 |
| 156 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.80755915 |
| 157 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.77722849 |
| 158 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.75140200 |
| 159 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.73920078 |
| 160 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.73786160 |
| 161 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.72992500 |
| 162 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.72799976 |
| 163 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.72300830 |
| 164 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.71830554 |
| 165 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.71705561 |
| 166 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.71288389 |
| 167 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.69093223 |
| 168 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.68583062 |
| 169 | * GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.68494254 |
| 170 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.68013779 |
| 171 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.67960035 |
| 172 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.67945792 |
| 173 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.67249886 |
| 174 | TBL1_22424771_ChIP-Seq_293T_Human | 0.66639350 |
| 175 | * LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.66401829 |
| 176 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.65788817 |
| 177 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.65683680 |
| 178 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.65059718 |
| 179 | * KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.64965775 |
| 180 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.64833913 |
| 181 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.64813217 |
| 182 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.64634090 |
| 183 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.64421930 |
| 184 | RXR_22108803_ChIP-Seq_LS180_Human | 0.64158623 |
| 185 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.64155679 |
| 186 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.63391828 |
| 187 | ERA_21632823_ChIP-Seq_H3396_Human | 0.63196651 |
| 188 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.63083219 |
| 189 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.62938676 |
| 190 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.61993206 |
| 191 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.61918542 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.86198139 |
| 2 | MP0005360_urolithiasis | 3.58082125 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.57863657 |
| 4 | MP0000569_abnormal_digit_pigmentation | 3.32957874 |
| 5 | MP0005365_abnormal_bile_salt | 3.20420854 |
| 6 | MP0003787_abnormal_imprinting | 2.69665605 |
| 7 | MP0008057_abnormal_DNA_replication | 2.58492668 |
| 8 | MP0004859_abnormal_synaptic_plasticity | 2.58392001 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 2.57891004 |
| 10 | MP0003646_muscle_fatigue | 2.50891252 |
| 11 | MP0004510_myositis | 2.38127506 |
| 12 | MP0009840_abnormal_foam_cell | 2.36792066 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.35060276 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 2.29630487 |
| 15 | MP0004130_abnormal_muscle_cell | 2.18152142 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 2.08396536 |
| 17 | MP0004145_abnormal_muscle_electrophysio | 2.01592681 |
| 18 | MP0005451_abnormal_body_composition | 2.00480137 |
| 19 | MP0004270_analgesia | 2.00185755 |
| 20 | MP0002166_altered_tumor_susceptibility | 1.98550420 |
| 21 | MP0005332_abnormal_amino_acid | 1.97481145 |
| 22 | MP0000747_muscle_weakness | 1.92573483 |
| 23 | MP0008877_abnormal_DNA_methylation | 1.90568065 |
| 24 | MP0000751_myopathy | 1.89313871 |
| 25 | MP0003329_amyloid_beta_deposits | 1.85896451 |
| 26 | MP0003303_peritoneal_inflammation | 1.75986755 |
| 27 | MP0005666_abnormal_adipose_tissue | 1.74027088 |
| 28 | MP0003718_maternal_effect | 1.73525177 |
| 29 | MP0004185_abnormal_adipocyte_glucose | 1.71116849 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.69865077 |
| 31 | MP0003724_increased_susceptibility_to | 1.68760290 |
| 32 | MP0003172_abnormal_lysosome_physiology | 1.64473255 |
| 33 | MP0008260_abnormal_autophagy | 1.64420998 |
| 34 | MP0005310_abnormal_salivary_gland | 1.62442185 |
| 35 | MP0003635_abnormal_synaptic_transmissio | 1.61831527 |
| 36 | MP0004036_abnormal_muscle_relaxation | 1.58227229 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.57847802 |
| 38 | MP0003045_fibrosis | 1.55627844 |
| 39 | MP0002269_muscular_atrophy | 1.51726780 |
| 40 | MP0005330_cardiomyopathy | 1.51630033 |
| 41 | MP0003705_abnormal_hypodermis_morpholog | 1.49742972 |
| 42 | MP0003300_gastrointestinal_ulcer | 1.49505704 |
| 43 | MP0002822_catalepsy | 1.47551928 |
| 44 | MP0001440_abnormal_grooming_behavior | 1.45820762 |
| 45 | MP0003828_pulmonary_edema | 1.45515310 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.44658111 |
| 47 | MP0003221_abnormal_cardiomyocyte_apopto | 1.43108155 |
| 48 | MP0004084_abnormal_cardiac_muscle | 1.42485254 |
| 49 | MP0009046_muscle_twitch | 1.38800012 |
| 50 | MP0003880_abnormal_central_pattern | 1.37732966 |
| 51 | MP0000750_abnormal_muscle_regeneration | 1.33103529 |
| 52 | MP0002009_preneoplasia | 1.31194951 |
| 53 | MP0006036_abnormal_mitochondrial_physio | 1.30190680 |
| 54 | MP0001661_extended_life_span | 1.28936545 |
| 55 | MP0008569_lethality_at_weaning | 1.28611075 |
| 56 | MP0002971_abnormal_brown_adipose | 1.27960951 |
| 57 | MP0003252_abnormal_bile_duct | 1.27789333 |
| 58 | MP0001835_abnormal_antigen_presentation | 1.27767297 |
| 59 | MP0010234_abnormal_vibrissa_follicle | 1.25386287 |
| 60 | MP0004215_abnormal_myocardial_fiber | 1.24240810 |
| 61 | MP0004019_abnormal_vitamin_homeostasis | 1.24121293 |
| 62 | MP0002064_seizures | 1.21779082 |
| 63 | MP0003633_abnormal_nervous_system | 1.19918075 |
| 64 | MP0004087_abnormal_muscle_fiber | 1.19599531 |
| 65 | MP0000609_abnormal_liver_physiology | 1.18577687 |
| 66 | MP0004885_abnormal_endolymph | 1.18123484 |
| 67 | MP0002063_abnormal_learning/memory/cond | 1.17826583 |
| 68 | MP0005379_endocrine/exocrine_gland_phen | 1.15671320 |
| 69 | MP0005423_abnormal_somatic_nervous | 1.15179625 |
| 70 | MP0005670_abnormal_white_adipose | 1.15071789 |
| 71 | MP0000015_abnormal_ear_pigmentation | 1.13060201 |
| 72 | MP0002734_abnormal_mechanical_nocicepti | 1.11449406 |
| 73 | MP0002006_tumorigenesis | 1.10991934 |
| 74 | MP0005375_adipose_tissue_phenotype | 1.10842502 |
| 75 | MP0004381_abnormal_hair_follicle | 1.09913745 |
| 76 | MP0006035_abnormal_mitochondrial_morpho | 1.09380992 |
| 77 | MP0002909_abnormal_adrenal_gland | 1.09207919 |
| 78 | MP0001348_abnormal_lacrimal_gland | 1.06777133 |
| 79 | MP0003191_abnormal_cellular_cholesterol | 1.06318187 |
| 80 | MP0000604_amyloidosis | 1.05949456 |
| 81 | MP0005083_abnormal_biliary_tract | 1.05393666 |
| 82 | MP0003195_calcinosis | 1.05002006 |
| 83 | MP0005620_abnormal_muscle_contractility | 1.03910893 |
| 84 | MP0002106_abnormal_muscle_physiology | 1.03084321 |
| 85 | MP0001666_abnormal_nutrient_absorption | 1.02728329 |
| 86 | MP0009745_abnormal_behavioral_response | 1.01598881 |
| 87 | MP0001765_abnormal_ion_homeostasis | 1.01338113 |
| 88 | MP0003631_nervous_system_phenotype | 1.01306385 |
| 89 | MP0002796_impaired_skin_barrier | 1.00841798 |
| 90 | MP0001501_abnormal_sleep_pattern | 1.00719717 |
| 91 | MP0010352_gastrointestinal_tract_polyps | 1.00164071 |
| 92 | MP0002972_abnormal_cardiac_muscle | 0.99688421 |
| 93 | MP0005535_abnormal_body_temperature | 0.99664110 |
| 94 | MP0005410_abnormal_fertilization | 0.99458158 |
| 95 | MP0002067_abnormal_sensory_capabilities | 0.99421927 |
| 96 | MP0005319_abnormal_enzyme/_coenzyme | 0.98866763 |
| 97 | MP0009672_abnormal_birth_weight | 0.98622896 |
| 98 | MP0002928_abnormal_bile_duct | 0.98288272 |
| 99 | MP0008874_decreased_physiological_sensi | 0.97765449 |
| 100 | MP0005409_darkened_coat_color | 0.97297935 |
| 101 | MP0003091_abnormal_cell_migration | 0.96083728 |
| 102 | MP0001486_abnormal_startle_reflex | 0.95988154 |
| 103 | MP0004233_abnormal_muscle_weight | 0.95965824 |
| 104 | MP0006138_congestive_heart_failure | 0.95191125 |
| 105 | MP0003690_abnormal_glial_cell | 0.95147876 |
| 106 | MP0005248_abnormal_Harderian_gland | 0.93638697 |
| 107 | MP0003763_abnormal_thymus_physiology | 0.93199702 |
| 108 | MP0003868_abnormal_feces_composition | 0.91355183 |
| 109 | MP0001730_embryonic_growth_arrest | 0.89232230 |
| 110 | MP0003879_abnormal_hair_cell | 0.86842815 |
| 111 | MP0000759_abnormal_skeletal_muscle | 0.86142586 |
| 112 | MP0005395_other_phenotype | 0.85871801 |
| 113 | MP0002693_abnormal_pancreas_physiology | 0.85349892 |
| 114 | MP0005187_abnormal_penis_morphology | 0.85174283 |
| 115 | MP0003698_abnormal_male_reproductive | 0.84869192 |
| 116 | MP0002272_abnormal_nervous_system | 0.84075567 |
| 117 | MP0009780_abnormal_chondrocyte_physiolo | 0.83968931 |
| 118 | MP0005369_muscle_phenotype | 0.83511665 |
| 119 | MP0005386_behavior/neurological_phenoty | 0.82550887 |
| 120 | MP0004924_abnormal_behavior | 0.82550887 |
| 121 | MP0003866_abnormal_defecation | 0.81843238 |
| 122 | MP0000427_abnormal_hair_cycle | 0.81483589 |
| 123 | MP0001800_abnormal_humoral_immune | 0.80969856 |
| 124 | MP0000685_abnormal_immune_system | 0.80848710 |
| 125 | MP0009115_abnormal_fat_cell | 0.80411299 |
| 126 | MP0002735_abnormal_chemical_nociception | 0.80322485 |
| 127 | MP0002733_abnormal_thermal_nociception | 0.79009743 |
| 128 | MP0003137_abnormal_impulse_conducting | 0.78433096 |
| 129 | MP0003111_abnormal_nucleus_morphology | 0.78249659 |
| 130 | MP0003693_abnormal_embryo_hatching | 0.77951464 |
| 131 | MP0001851_eye_inflammation | 0.77459276 |
| 132 | MP0004883_abnormal_blood_vessel | 0.77205218 |
| 133 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.76965425 |
| 134 | MP0004147_increased_porphyrin_level | 0.76609835 |
| 135 | MP0003632_abnormal_nervous_system | 0.76350340 |
| 136 | MP0005334_abnormal_fat_pad | 0.75750056 |
| 137 | MP0002572_abnormal_emotion/affect_behav | 0.74207320 |
| 138 | MP0002229_neurodegeneration | 0.73924617 |
| 139 | MP0002066_abnormal_motor_capabilities/c | 0.73646605 |
| 140 | MP0001764_abnormal_homeostasis | 0.73524199 |
| 141 | MP0000749_muscle_degeneration | 0.73047910 |
| 142 | MP0010678_abnormal_skin_adnexa | 0.72435051 |
| 143 | MP0002127_abnormal_cardiovascular_syste | 0.72358975 |
| 144 | MP0002078_abnormal_glucose_homeostasis | 0.71972733 |
| 145 | MP0004484_altered_response_of | 0.71572111 |
| 146 | MP0004085_abnormal_heartbeat | 0.68585144 |
| 147 | MP0003656_abnormal_erythrocyte_physiolo | 0.68333175 |
| 148 | MP0002332_abnormal_exercise_endurance | 0.67946629 |
| 149 | MP0004858_abnormal_nervous_system | 0.66676290 |
| 150 | MP0003123_paternal_imprinting | 0.65463274 |
| 151 | MP0005266_abnormal_metabolism | 0.65365435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperglycinemia (HP:0002154) | 5.54148827 |
| 2 | Hyperglycinuria (HP:0003108) | 4.96307660 |
| 3 | Abnormality of glycine metabolism (HP:0010895) | 4.51614754 |
| 4 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.51614754 |
| 5 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 4.32789277 |
| 6 | Papillary thyroid carcinoma (HP:0002895) | 4.24280633 |
| 7 | Muscle fiber splitting (HP:0003555) | 3.93969995 |
| 8 | Bundle branch block (HP:0011710) | 3.73199556 |
| 9 | Gout (HP:0001997) | 3.71062343 |
| 10 | Febrile seizures (HP:0002373) | 3.67094646 |
| 11 | Atrioventricular block (HP:0001678) | 3.64887383 |
| 12 | Ventricular fibrillation (HP:0001663) | 3.61579086 |
| 13 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.50388072 |
| 14 | Subaortic stenosis (HP:0001682) | 3.50388072 |
| 15 | Deep venous thrombosis (HP:0002625) | 3.43227619 |
| 16 | Xanthomatosis (HP:0000991) | 3.37968749 |
| 17 | Hyperlipoproteinemia (HP:0010980) | 3.30664833 |
| 18 | Hyperkalemia (HP:0002153) | 3.21412606 |
| 19 | Abnormality of serum amino acid levels (HP:0003112) | 3.19865463 |
| 20 | Nemaline bodies (HP:0003798) | 3.14962634 |
| 21 | Hypobetalipoproteinemia (HP:0003563) | 3.07553891 |
| 22 | Intrahepatic cholestasis (HP:0001406) | 3.07332242 |
| 23 | Focal motor seizures (HP:0011153) | 3.04111263 |
| 24 | Calf muscle hypertrophy (HP:0008981) | 2.97718004 |
| 25 | Exercise-induced myalgia (HP:0003738) | 2.95234775 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 2.95097246 |
| 27 | Abnormality of the Achilles tendon (HP:0005109) | 2.93773562 |
| 28 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.86979574 |
| 29 | Hypolipoproteinemia (HP:0010981) | 2.86133966 |
| 30 | Global brain atrophy (HP:0002283) | 2.84220747 |
| 31 | Abnormality of the lower motor neuron (HP:0002366) | 2.82810868 |
| 32 | Heart block (HP:0012722) | 2.81094119 |
| 33 | Myokymia (HP:0002411) | 2.78884138 |
| 34 | Thyroid carcinoma (HP:0002890) | 2.78576056 |
| 35 | Achilles tendon contracture (HP:0001771) | 2.73460314 |
| 36 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.73137026 |
| 37 | Poikilocytosis (HP:0004447) | 2.72505379 |
| 38 | Abnormal atrioventricular conduction (HP:0005150) | 2.69944932 |
| 39 | Atonic seizures (HP:0010819) | 2.69365397 |
| 40 | Hypochromic microcytic anemia (HP:0004840) | 2.68645368 |
| 41 | Resting tremor (HP:0002322) | 2.66651922 |
| 42 | Tetraplegia (HP:0002445) | 2.66395878 |
| 43 | Areflexia of lower limbs (HP:0002522) | 2.65220649 |
| 44 | Hyperglycemia (HP:0003074) | 2.62435734 |
| 45 | Hyperammonemia (HP:0001987) | 2.61333268 |
| 46 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.61116723 |
| 47 | Difficulty climbing stairs (HP:0003551) | 2.60330993 |
| 48 | Papilledema (HP:0001085) | 2.59588166 |
| 49 | Prolonged bleeding time (HP:0003010) | 2.59233762 |
| 50 | Testicular neoplasm (HP:0010788) | 2.57267133 |
| 51 | Progressive cerebellar ataxia (HP:0002073) | 2.56982366 |
| 52 | Hyporeflexia of lower limbs (HP:0002600) | 2.54495953 |
| 53 | Gingival bleeding (HP:0000225) | 2.53204738 |
| 54 | Truncal obesity (HP:0001956) | 2.52256838 |
| 55 | Menstrual irregularities (HP:0000858) | 2.50281946 |
| 56 | Insidious onset (HP:0003587) | 2.45871205 |
| 57 | Termporal pattern (HP:0011008) | 2.45871205 |
| 58 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.45706746 |
| 59 | Slow saccadic eye movements (HP:0000514) | 2.43568225 |
| 60 | Hyperuricemia (HP:0002149) | 2.43011165 |
| 61 | Increased purine levels (HP:0004368) | 2.43011165 |
| 62 | Delusions (HP:0000746) | 2.42146081 |
| 63 | Shoulder girdle muscle weakness (HP:0003547) | 2.40709285 |
| 64 | Mutism (HP:0002300) | 2.36524339 |
| 65 | Fetal akinesia sequence (HP:0001989) | 2.35327958 |
| 66 | Eczematoid dermatitis (HP:0000976) | 2.35172494 |
| 67 | Focal seizures (HP:0007359) | 2.33742305 |
| 68 | Sudden death (HP:0001699) | 2.29360481 |
| 69 | Ketosis (HP:0001946) | 2.28630302 |
| 70 | Frequent falls (HP:0002359) | 2.26628593 |
| 71 | EMG: myopathic abnormalities (HP:0003458) | 2.26378889 |
| 72 | Male infertility (HP:0003251) | 2.23323489 |
| 73 | Exercise-induced muscle cramps (HP:0003710) | 2.20058561 |
| 74 | Visual hallucinations (HP:0002367) | 2.19588322 |
| 75 | Epidermoid cyst (HP:0200040) | 2.19327858 |
| 76 | Pelvic girdle muscle weakness (HP:0003749) | 2.18269692 |
| 77 | Recurrent bacterial skin infections (HP:0005406) | 2.18210687 |
| 78 | Dysmetric saccades (HP:0000641) | 2.17823041 |
| 79 | T lymphocytopenia (HP:0005403) | 2.17756085 |
| 80 | Cerebral hypomyelination (HP:0006808) | 2.17497769 |
| 81 | Asymmetric septal hypertrophy (HP:0001670) | 2.17306730 |
| 82 | Multiple enchondromatosis (HP:0005701) | 2.13812633 |
| 83 | Gaze-evoked nystagmus (HP:0000640) | 2.13207271 |
| 84 | Gingivitis (HP:0000230) | 2.11313592 |
| 85 | Spontaneous hematomas (HP:0007420) | 2.10834064 |
| 86 | Difficulty running (HP:0009046) | 2.10803688 |
| 87 | Cerebral inclusion bodies (HP:0100314) | 2.06551946 |
| 88 | Spastic tetraparesis (HP:0001285) | 2.06241933 |
| 89 | Complement deficiency (HP:0004431) | 2.05976374 |
| 90 | Syncope (HP:0001279) | 2.05868658 |
| 91 | Genetic anticipation (HP:0003743) | 2.05385194 |
| 92 | Impulsivity (HP:0100710) | 2.04874151 |
| 93 | Acanthocytosis (HP:0001927) | 2.04601149 |
| 94 | Hypoplastic ischia (HP:0003175) | 2.00927157 |
| 95 | Lethargy (HP:0001254) | 1.99671941 |
| 96 | Impaired social interactions (HP:0000735) | 1.98853589 |
| 97 | Abnormal social behavior (HP:0012433) | 1.98853589 |
| 98 | Muscle fiber inclusion bodies (HP:0100299) | 1.98842000 |
| 99 | Abnormality of T cell number (HP:0011839) | 1.98624977 |
| 100 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.97694357 |
| 101 | Abnormality of the fingertips (HP:0001211) | 1.97633234 |
| 102 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.96225333 |
| 103 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.96225333 |
| 104 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.95569264 |
| 105 | Progressive muscle weakness (HP:0003323) | 1.95039503 |
| 106 | Type 1 muscle fiber predominance (HP:0003803) | 1.94188216 |
| 107 | Abnormal cartilage morphology (HP:0002763) | 1.94104723 |
| 108 | Alveolar cell carcinoma (HP:0006519) | 1.93554399 |
| 109 | Status epilepticus (HP:0002133) | 1.93467803 |
| 110 | Ventricular arrhythmia (HP:0004308) | 1.92628832 |
| 111 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.92406244 |
| 112 | Abnormality of potassium homeostasis (HP:0011042) | 1.92124697 |
| 113 | Biliary tract neoplasm (HP:0100574) | 1.92007743 |
| 114 | Increased connective tissue (HP:0009025) | 1.91201214 |
| 115 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.90330100 |
| 116 | Ankle clonus (HP:0011448) | 1.89818253 |
| 117 | Generalized tonic-clonic seizures (HP:0002069) | 1.89208047 |
| 118 | Generalized hypopigmentation of hair (HP:0011358) | 1.89164194 |
| 119 | Abnormality of the ischium (HP:0003174) | 1.87988836 |
| 120 | Germ cell neoplasia (HP:0100728) | 1.87905736 |
| 121 | Abnormality of the labia minora (HP:0012880) | 1.87602424 |
| 122 | Gastrointestinal infarctions (HP:0005244) | 1.87573067 |
| 123 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.86939200 |
| 124 | Pheochromocytoma (HP:0002666) | 1.85863056 |
| 125 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.85477557 |
| 126 | Microcytic anemia (HP:0001935) | 1.85359567 |
| 127 | Subacute progressive viral hepatitis (HP:0006572) | 1.84184097 |
| 128 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.83901778 |
| 129 | Volvulus (HP:0002580) | 1.83210601 |
| 130 | Abnormality of chloride homeostasis (HP:0011422) | 1.82532357 |
| 131 | Restlessness (HP:0000711) | 1.82222155 |
| 132 | Action tremor (HP:0002345) | 1.81485452 |
| 133 | Abnormality of purine metabolism (HP:0004352) | 1.81446214 |
| 134 | Prolonged partial thromboplastin time (HP:0003645) | 1.80748305 |
| 135 | Abnormal platelet volume (HP:0011876) | 1.80678436 |
| 136 | Increased mean platelet volume (HP:0011877) | 1.80676588 |
| 137 | Thyroiditis (HP:0100646) | 1.80511388 |
| 138 | Fair hair (HP:0002286) | 1.80233901 |
| 139 | Myoglobinuria (HP:0002913) | 1.79681305 |
| 140 | Irritability (HP:0000737) | 1.79513250 |
| 141 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.79234338 |
| 142 | Abnormality of the calf musculature (HP:0001430) | 1.79227454 |
| 143 | Absence seizures (HP:0002121) | 1.78088048 |
| 144 | Impaired vibratory sensation (HP:0002495) | 1.75829349 |
| 145 | Childhood onset (HP:0011463) | 1.74579031 |
| 146 | Postural instability (HP:0002172) | 1.73221838 |
| 147 | Cholelithiasis (HP:0001081) | 1.72522948 |
| 148 | Recurrent abscess formation (HP:0002722) | 1.72496064 |
| 149 | Abnormality of saccadic eye movements (HP:0000570) | 1.72396743 |
| 150 | Testicular atrophy (HP:0000029) | 1.71776952 |
| 151 | Cystic hygroma (HP:0000476) | 1.71648197 |
| 152 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.71546976 |
| 153 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.70583802 |
| 154 | EMG: neuropathic changes (HP:0003445) | 1.70502346 |
| 155 | Polycythemia (HP:0001901) | 1.70403087 |
| 156 | Neurofibrillary tangles (HP:0002185) | 1.70352460 |
| 157 | Urinary urgency (HP:0000012) | 1.69028419 |
| 158 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.68201711 |
| 159 | Increased circulating renin level (HP:0000848) | 1.67843005 |
| 160 | Oligomenorrhea (HP:0000876) | 1.67654700 |
| 161 | Rhabdomyolysis (HP:0003201) | 1.67549444 |
| 162 | Rimmed vacuoles (HP:0003805) | 1.67504871 |
| 163 | Dialeptic seizures (HP:0011146) | 1.67454961 |
| 164 | Ventricular tachycardia (HP:0004756) | 1.66480966 |
| 165 | Ureteral duplication (HP:0000073) | 1.66380157 |
| 166 | Myotonia (HP:0002486) | 1.66375127 |
| 167 | Epistaxis (HP:0000421) | 1.66228926 |
| 168 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.65925187 |
| 169 | Chest pain (HP:0100749) | 1.65570002 |
| 170 | Curly hair (HP:0002212) | 1.65059558 |
| 171 | Retrobulbar optic neuritis (HP:0100654) | 1.64642346 |
| 172 | Optic neuritis (HP:0100653) | 1.64642346 |
| 173 | Hyperventilation (HP:0002883) | 1.64463260 |
| 174 | Epileptic encephalopathy (HP:0200134) | 1.63143688 |
| 175 | Bladder neoplasm (HP:0009725) | 1.62927313 |
| 176 | Bladder carcinoma (HP:0002862) | 1.62927313 |
| 177 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.58770858 |
| 178 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.58770858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS2 | 3.42972828 |
| 2 | FRK | 3.41942065 |
| 3 | PNCK | 3.34183635 |
| 4 | MAP3K9 | 3.17006748 |
| 5 | PDK3 | 3.15823548 |
| 6 | PDK4 | 3.15823548 |
| 7 | RIPK4 | 2.59942752 |
| 8 | SGK2 | 2.41110132 |
| 9 | NEK1 | 2.40275379 |
| 10 | PINK1 | 2.35324277 |
| 11 | AKT3 | 2.21463459 |
| 12 | PDK2 | 2.21020704 |
| 13 | PIK3CG | 2.19107385 |
| 14 | EPHA4 | 2.17244663 |
| 15 | WEE1 | 2.16986535 |
| 16 | KSR2 | 1.91551244 |
| 17 | FGFR3 | 1.89805706 |
| 18 | MAP2K4 | 1.85996432 |
| 19 | LATS1 | 1.85685391 |
| 20 | PAK6 | 1.83390844 |
| 21 | PLK2 | 1.82755486 |
| 22 | ALK | 1.81539869 |
| 23 | BCKDK | 1.79094995 |
| 24 | WNK1 | 1.77319706 |
| 25 | PHKG2 | 1.76687249 |
| 26 | PHKG1 | 1.76687249 |
| 27 | ARAF | 1.74957596 |
| 28 | STK38 | 1.71665388 |
| 29 | TRIB3 | 1.67116785 |
| 30 | SGK223 | 1.66310978 |
| 31 | SGK494 | 1.66310978 |
| 32 | PRKD3 | 1.65325966 |
| 33 | MARK1 | 1.65305450 |
| 34 | ACVR1B | 1.56741377 |
| 35 | BRD4 | 1.55680360 |
| 36 | FES | 1.52549103 |
| 37 | MAP3K4 | 1.52519692 |
| 38 | TRPM7 | 1.45104925 |
| 39 | PTK2B | 1.39373380 |
| 40 | BMPR2 | 1.38563983 |
| 41 | NLK | 1.35874420 |
| 42 | CAMK1G | 1.31020235 |
| 43 | TSSK6 | 1.29768895 |
| 44 | STK38L | 1.27499941 |
| 45 | MAP2K3 | 1.21310777 |
| 46 | NTRK3 | 1.20805465 |
| 47 | LMTK2 | 1.20285772 |
| 48 | NTRK1 | 1.19509802 |
| 49 | GRK5 | 1.16511958 |
| 50 | CAMKK2 | 1.16394003 |
| 51 | TYRO3 | 1.16240694 |
| 52 | DAPK2 | 1.12457855 |
| 53 | JAK1 | 1.12112661 |
| 54 | MAP3K1 | 1.11325132 |
| 55 | TAOK1 | 1.10873121 |
| 56 | MINK1 | 1.08898924 |
| 57 | PRKAA1 | 1.03682502 |
| 58 | MAP3K13 | 1.02879037 |
| 59 | STK3 | 1.00925291 |
| 60 | NEK2 | 1.00264812 |
| 61 | SGK1 | 0.99567110 |
| 62 | IKBKE | 0.98979275 |
| 63 | TTN | 0.97499234 |
| 64 | OBSCN | 0.97491467 |
| 65 | PRPF4B | 0.97092921 |
| 66 | ICK | 0.96082305 |
| 67 | CASK | 0.95914469 |
| 68 | FGR | 0.95631597 |
| 69 | YES1 | 0.94694663 |
| 70 | TAOK3 | 0.93906935 |
| 71 | STK11 | 0.90962238 |
| 72 | PDPK1 | 0.90716822 |
| 73 | BLK | 0.89774317 |
| 74 | BUB1 | 0.89546751 |
| 75 | MAP3K2 | 0.89124545 |
| 76 | NEK6 | 0.88456460 |
| 77 | SYK | 0.87823736 |
| 78 | PAK3 | 0.87770523 |
| 79 | PRKCG | 0.87448043 |
| 80 | CAMK1 | 0.87379480 |
| 81 | ERBB3 | 0.86157838 |
| 82 | UHMK1 | 0.85777745 |
| 83 | PLK3 | 0.84907983 |
| 84 | JAK2 | 0.84319033 |
| 85 | RAF1 | 0.83881372 |
| 86 | BRSK1 | 0.83384030 |
| 87 | GRK6 | 0.81586898 |
| 88 | CSNK1G2 | 0.81548066 |
| 89 | MAP3K6 | 0.80835581 |
| 90 | MAP3K7 | 0.78852651 |
| 91 | CSK | 0.77326891 |
| 92 | ABL2 | 0.76972284 |
| 93 | MARK2 | 0.76087884 |
| 94 | RET | 0.75661992 |
| 95 | PKN2 | 0.75606535 |
| 96 | DYRK1A | 0.75068993 |
| 97 | CSNK1E | 0.74531119 |
| 98 | TNIK | 0.74383406 |
| 99 | TTK | 0.73605279 |
| 100 | CAMK4 | 0.73564980 |
| 101 | IRAK1 | 0.73353799 |
| 102 | PIK3CA | 0.73338619 |
| 103 | EIF2AK1 | 0.71463911 |
| 104 | ERBB4 | 0.70700426 |
| 105 | PDK1 | 0.70597519 |
| 106 | DDR2 | 0.70582883 |
| 107 | CAMKK1 | 0.70083723 |
| 108 | KSR1 | 0.67550015 |
| 109 | FER | 0.67000528 |
| 110 | STK39 | 0.63055185 |
| 111 | STK4 | 0.62838483 |
| 112 | MAP3K5 | 0.62815795 |
| 113 | NME1 | 0.60297828 |
| 114 | BTK | 0.59904617 |
| 115 | CSNK1G1 | 0.59485898 |
| 116 | NTRK2 | 0.59019968 |
| 117 | STK24 | 0.58870926 |
| 118 | TEC | 0.58731274 |
| 119 | BRSK2 | 0.58569733 |
| 120 | HCK | 0.57534568 |
| 121 | MST4 | 0.57166870 |
| 122 | BRAF | 0.56939119 |
| 123 | MAP2K1 | 0.56874250 |
| 124 | HIPK2 | 0.56854216 |
| 125 | ERBB2 | 0.56283073 |
| 126 | PLK1 | 0.54530893 |
| 127 | CAMK2G | 0.54498944 |
| 128 | CDK5 | 0.54217447 |
| 129 | MELK | 0.52044740 |
| 130 | MAP3K14 | 0.51399308 |
| 131 | CSNK1G3 | 0.50882776 |
| 132 | RIPK1 | 0.50609183 |
| 133 | NEK9 | 0.50518799 |
| 134 | IRAK2 | 0.50488831 |
| 135 | MAP2K7 | 0.49404748 |
| 136 | MAPK10 | 0.49251305 |
| 137 | CDK12 | 0.49088794 |
| 138 | FGFR2 | 0.48944884 |
| 139 | TYK2 | 0.48102269 |
| 140 | PRKAA2 | 0.45892904 |
| 141 | RPS6KA3 | 0.45312875 |
| 142 | MAPK13 | 0.45243144 |
| 143 | CDK14 | 0.45198684 |
| 144 | PRKCZ | 0.44386985 |
| 145 | PRKG1 | 0.44263162 |
| 146 | IRAK4 | 0.43946489 |
| 147 | BMX | 0.43852087 |
| 148 | CDK15 | 0.40662539 |
| 149 | CAMK2A | 0.39681183 |
| 150 | PDGFRA | 0.38768869 |
| 151 | MTOR | 0.38622424 |
| 152 | GSK3A | 0.37541050 |
| 153 | DMPK | 0.37428658 |
| 154 | PRKACG | 0.37155203 |
| 155 | OXSR1 | 0.36669376 |
| 156 | AURKA | 0.35967494 |
| 157 | MAPK12 | 0.34968805 |
| 158 | SGK3 | 0.34804321 |
| 159 | CDK11A | 0.33196303 |
| 160 | CDK18 | 0.32084350 |
| 161 | CSNK1D | 0.29845942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.67323586 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.54238726 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.16186818 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.91835058 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.64018694 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.62294894 |
| 7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.46532175 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.24992746 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.24991837 |
| 10 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.09903241 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.08823588 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.97042092 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.94765318 |
| 14 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.79957374 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.75273463 |
| 16 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.73725069 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.69057738 |
| 18 | Carbon metabolism_Homo sapiens_hsa01200 | 1.60030472 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.55282713 |
| 20 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.53848316 |
| 21 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.52643716 |
| 22 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.51249864 |
| 23 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.48559325 |
| 24 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.47380615 |
| 25 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.46646011 |
| 26 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.45710447 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.43288420 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.43287549 |
| 29 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.40318178 |
| 30 | Platelet activation_Homo sapiens_hsa04611 | 1.39545378 |
| 31 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.36218368 |
| 32 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.35517116 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.33762517 |
| 34 | Insulin secretion_Homo sapiens_hsa04911 | 1.31550813 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.29903801 |
| 36 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.27122827 |
| 37 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.26088974 |
| 38 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.24537470 |
| 39 | Endometrial cancer_Homo sapiens_hsa05213 | 1.22786665 |
| 40 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.21767460 |
| 41 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.20543394 |
| 42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.19481040 |
| 43 | Long-term depression_Homo sapiens_hsa04730 | 1.18255906 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.16788779 |
| 45 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.15135761 |
| 46 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.14381411 |
| 47 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.12990755 |
| 48 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.11391103 |
| 49 | Glioma_Homo sapiens_hsa05214 | 1.10884448 |
| 50 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.10732233 |
| 51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.10229038 |
| 52 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.06810721 |
| 53 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.04003569 |
| 54 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.03834937 |
| 55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.00731909 |
| 56 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.99852164 |
| 57 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.98546541 |
| 58 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.98258683 |
| 59 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.97661138 |
| 60 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.96801799 |
| 61 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.96670102 |
| 62 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.96222577 |
| 63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.96187880 |
| 64 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.95235846 |
| 65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.94189361 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.94060286 |
| 67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.92073939 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.91544662 |
| 69 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.90772893 |
| 70 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.90434883 |
| 71 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.90019489 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88068336 |
| 73 | Peroxisome_Homo sapiens_hsa04146 | 0.87148427 |
| 74 | Morphine addiction_Homo sapiens_hsa05032 | 0.87052529 |
| 75 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.86019166 |
| 76 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.84365384 |
| 77 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.84284454 |
| 78 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.83286398 |
| 79 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83005102 |
| 80 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.82898123 |
| 81 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.81760462 |
| 82 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.80883736 |
| 83 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80273318 |
| 84 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80143829 |
| 85 | ABC transporters_Homo sapiens_hsa02010 | 0.78781190 |
| 86 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.77995293 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77172260 |
| 88 | Leishmaniasis_Homo sapiens_hsa05140 | 0.76234427 |
| 89 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.75342249 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.74795627 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.74260912 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.74126539 |
| 93 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.71805097 |
| 94 | Retinol metabolism_Homo sapiens_hsa00830 | 0.71691151 |
| 95 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.71118540 |
| 96 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.70840888 |
| 97 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.70206838 |
| 98 | Nicotine addiction_Homo sapiens_hsa05033 | 0.70110802 |
| 99 | GABAergic synapse_Homo sapiens_hsa04727 | 0.70106896 |
| 100 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.70050384 |
| 101 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69848680 |
| 102 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.69814816 |
| 103 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69463821 |
| 104 | Prostate cancer_Homo sapiens_hsa05215 | 0.68369495 |
| 105 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.67973576 |
| 106 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.67794870 |
| 107 | Tuberculosis_Homo sapiens_hsa05152 | 0.67147722 |
| 108 | Taste transduction_Homo sapiens_hsa04742 | 0.66557268 |
| 109 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.66233965 |
| 110 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.65723109 |
| 111 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.65502280 |
| 112 | Long-term potentiation_Homo sapiens_hsa04720 | 0.65013987 |
| 113 | Histidine metabolism_Homo sapiens_hsa00340 | 0.64467410 |
| 114 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.64294571 |
| 115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63897397 |
| 116 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.63562756 |
| 117 | Measles_Homo sapiens_hsa05162 | 0.63514222 |
| 118 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.62543081 |
| 119 | Gap junction_Homo sapiens_hsa04540 | 0.62351713 |
| 120 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61235638 |
| 121 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.61018353 |
| 122 | Circadian rhythm_Homo sapiens_hsa04710 | 0.60889302 |
| 123 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60730378 |
| 124 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60254165 |
| 125 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.60028237 |
| 126 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.59511756 |
| 127 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.58525997 |
| 128 | Olfactory transduction_Homo sapiens_hsa04740 | 0.58403780 |
| 129 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.58238712 |
| 130 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.57668302 |
| 131 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.57268501 |
| 132 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56654160 |
| 133 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.56250823 |
| 134 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.54371492 |
| 135 | Influenza A_Homo sapiens_hsa05164 | 0.53646945 |
| 136 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.52637173 |
| 137 | Endocytosis_Homo sapiens_hsa04144 | 0.52216297 |
| 138 | Cocaine addiction_Homo sapiens_hsa05030 | 0.52120107 |
| 139 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.51560382 |
| 140 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.51045142 |
| 141 | Salivary secretion_Homo sapiens_hsa04970 | 0.46436863 |
| 142 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.45507704 |
| 143 | Insulin resistance_Homo sapiens_hsa04931 | 0.45336622 |
| 144 | RNA polymerase_Homo sapiens_hsa03020 | 0.45175885 |
| 145 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.44976764 |
| 146 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.43392168 |
| 147 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.42243285 |
| 148 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.40490226 |
| 149 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.39954541 |
| 150 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39028930 |
| 151 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.38385954 |
| 152 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.38102859 |
| 153 | Prion diseases_Homo sapiens_hsa05020 | 0.37758601 |
| 154 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37050732 |
| 155 | RNA transport_Homo sapiens_hsa03013 | 0.36965776 |
| 156 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36586443 |
| 157 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36310251 |
| 158 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.35745694 |
| 159 | Circadian entrainment_Homo sapiens_hsa04713 | 0.34952171 |
| 160 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33836952 |
| 161 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.33770164 |
| 162 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.31771774 |

